EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolic disruption impairs ribosomal protein levels, resulting in enhanced aminoglycoside tolerance

Rauf Shiraliyev iD, Mehmet A Orman iD

eLife · 2024

DOI: 10.7554/elife.94903 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Rauf Shiraliyev und 1 weiteren Autor:innen. Beteiligte Einrichtung: William A. Brookshire Department of Chemical and Biomolecular Engineering, University of Houston, Houston, United States. Hauptthemen laut MEDLINE: Ribosomal Proteins, Aminoglycosides, Anti-Bacterial Agents, Escherichia coli. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NSF CAREER, NIAID NIH HHS, NIH/NIAID.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aminoglycoside antibiotics target ribosomes and are effective against a wide range of bacteria. Here, we demonstrated that knockout strains related to energy metabolism in Escherichia coli showed increased tolerance to aminoglycosides during the mid-exponential growth phase. Contrary to expectations, these mutations did not reduce the proton motive force or aminoglycoside uptake, as there were no significant changes in metabolic indicators or intracellular gentamicin levels between wild-type and mutant strains. Our comprehensive proteomics analysis unveiled a noteworthy upregulation of proteins linked to the tricarboxylic acid (TCA) cycle in the mutant strains during the mid-exponential growth phase, suggesting that these strains compensate for the perturbation in their energy metabolism by increasing TCA cycle activity to maintain their membrane potential and ATP levels. Furthermore, our pathway enrichment analysis shed light on local network clusters displaying downregulation across all mutant strains, which were associated with both large and small ribosomal binding proteins, ribosome biogenesis, translation factor activity, and the biosynthesis of ribonucleoside monophosphates. These findings offer a plausible explanation for the observed tolerance of aminoglycosides in the mutant strains. Altogether, this research provides valuable insights into the mechanisms of aminoglycoside tolerance, paving the way for novel strategies to combat such cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ribosomal ProteinsAminoglycosidesAnti-Bacterial AgentsEscherichia coliEnergy MetabolismEscherichia coli ProteinsDrug ToleranceProteomicsCitric Acid Cycle

Stichwörter der Autor:innen

E. coliaminoglycosideantibiotic toleranceenergy metabolisminfectious diseasemicrobiologyproteomics

Substanzen

Ribosomal ProteinsAminoglycosidesAnti-Bacterial AgentsEscherichia coli Proteins

Autor:innen und Institutionen

  • William A. Brookshire Department of Chemical and Biomolecular Engineering, University of Houston, Houston, United States.

ORCID-Profile: Rauf Shiraliyev, Mehmet A Orman

Förderung

  • NSF CAREER
  • NIAID NIH HHS
  • NIH/NIAID
  • National Institute of Allergy and Infectious Diseases
  • National Science Foundation

Zitieren

APA

Shiraliyev, R., & Orman, M. A. (2024). Metabolic disruption impairs ribosomal protein levels, resulting in enhanced aminoglycoside tolerance. eLife. https://doi.org/10.7554/elife.94903

Vancouver

Shiraliyev R, Orman MA. Metabolic disruption impairs ribosomal protein levels, resulting in enhanced aminoglycoside tolerance. eLife. 2024. doi:10.7554/elife.94903

BibTeX
@article{Shiraliyev2024,
  author = {Shiraliyev, Rauf and Orman, Mehmet A},
  title = {Metabolic disruption impairs ribosomal protein levels, resulting in enhanced aminoglycoside tolerance},
  journal = {eLife},
  year = {2024},
  doi = {10.7554/elife.94903}
}
Kostenlos starten →